|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Homocysteine,vitamin B12 and folate levels in Iranian patients with ischemic stroke显示文摘 | Moghanddasi M Mamarabadi M Mirzadeh S | | 0，，09： | 1 |
| 2 | Hypothyroidism the main thyroid dysfunction in Iranian patients with myasthenia gravis : a case serie显示文摘 | Mamarabadi M Razjouyan H Moghaddasi M | 2011 | Iran J Neurol2011，10，12： | 1 |
| 3 | Serum 25- hydroxyvitamin D3 concentration in Iranian patients with Parkinson' s disease显示文摘 | Moghaddasi M Mamarabadi M Aghaii M | 2013 | Iran J Neurol2013，12，： | 1 |
| 4 | Real-time RT-PCR expression analysis of chitinase and endoglucanase genes in the three-way interaction between the biocontrol strain Clonostachys rosea IK726,Botrytis cinerea and strawberry显示文摘 | Mamarabadi M Jensen B Jensen D F | 2008 | FEMS Microbiology Letters2008，285，1： | 1 |
| 5 | Serum 25-hy- droxyvitamin D3 concentration in Iranian patients with Parkinson' s disease显示文摘 | Moghaddasi M Mamarabadi M Aghaii M | 2013 | Iran J Neurol2013，12，2： | 1 |
| 6 | Ho-mocysteine, vitamin B12 and folate levels in Iranian patientswith ischemic stroke 显示文摘 | MOGHADDASI M MAMARABADI M MIRZADEH S | 2010 | Neurological Research2010，26，9： | 1 |
| 7 | Homocysteine, vitamin B12 and folate levels in Iranian patients with ischemic stroke显示文摘 | Moghaddasi M Mamarabadi M Mirzadeh S | 2010 | Neurol Res2010，32，9： | 1 |
| 8 | Homocysteine,vitami-nB12 and folate levels in Iranian patients with ischemic stroke显示文摘 | Moghaddasi M Mamarabadi MtMirzadeh S | 2010 | Neurol Res2010，32，9： | 1 |
| 9 | Homocysteine,vitamin B12 and folate levels in Iranian patients with ischemic stroke显示文摘 | Moghaddasi M Mamarabadi M Mirzadeh S | | 0，，09： | 1 |
| 10 | Homocysteine, vi- tamin B12 and folate levels in Iranian patients with ischemic stroke 显示文摘 | Moghaddasi M Mamarabadi M Mirzadeh S | 2010 | Neurological research2010，32，： | 1 |
| 11 | Homocysteine,vitamin B12and folate levels in Iranian patients with ischemicstroke显示文摘 | Moghaddasi M Mamarabadi M Mirzadeh S | 2010 | Neurol Res2010，32，9： | 1 |
| 12 | Ho mocysteine, vitamin B12 and folate levels in Iranian pa- tients with ischemic stroke显示文摘 | Moghaddasi M Mamarabadi M Mirzadeh S | 2010 | Neurological Research2010，32，9： | 1 |
| 13 | Homocysteine, vitamin B12 and folate levels in Iranian patients with isehemic stroke显示文摘 | Moghaddasi M Mamarabadi M Mirzadeh S | 2010 | Neurol Res2010，32，9： | 1 |
| 14 | Homocysteine, vitamin B12 and folate levels in Iranian patients with ischemic stroke显示文摘 | Moghaddasi M Mamarabadi M Mirzadeh S | 2010 | Neurol Res2010，32，9： | 1 |
| 15 | Homocys- teine,vitamin Baa and folate levels in Iranian patients with is- chemic stroke显示文摘 | Moghadddsi M Mamarabadi M Mirzadeh S | 2010 | Neurol Res2010，32，9： | 1 |
| 16 | Serum 25 - hydmxyvitamin D3 concentration in Iranian patients with Parkinson's disease 显示文摘 | Moghaddasi M Mamarabadi M Aghaii M | 2013 | ][ran ] Neurol2013，2，2： | 1 |
| 17 | Towards understanding the ecology and mechanisms of biocontrol of Clonostachys rosea IK726显示文摘Clonostachys rosea (syn. Gliocladium roseum) IK726 was originally selected as an effective biocontrol agent (BCA) against cereal seed borne diseases caused by Fusarium culmorum and Bipolaris sorokiniana. We have studied the efficacy of the antagonist against different pathogens in several crops and found that the antagonist also is able to control Alternaria radicina and A. dauci on carrot seeds and different cold-storage fungi in acorns. IK726 is also able to reduce severity of soil borne Pythium spp. in cabbage, carrot and sugar beet. In addition, growth-promoting effects of IK726 have been demonstrated in barley and tomato. In order to develop and improve application methods and control strategies, essential basic studies of ecology and the mechanisms of control of IK726 is needed and has led us to use various molecular tools. The UP-PCR technology is used for strain recognition and we have developed GUS and GFP-transformants that resembles the wildtype strain in ecological fitness parameters. Using either the GUS-transformant or UP-PCR we have found that IK726, when applied with seeds, reproduces and survives several months in the rhizosphere of field grown barley and carrot. The GFP-transformant is used to study the behavior and in situ interactions of the antagonist with pathogens and plants. Using the GFP marker, we have observed conidial germination, colonization and conidiogenesis in natural soil, in vermiculite and on carrot and barley seed and roots and on barley leaves. Moreover in situ interactions with Alternaria on carrot material have been studied. The modes of action of C. rosea are not well understood but enzymatic activity, mycoparasitism, substrate competition, antibiosis and induced resistance are thought to play a role. Barley treated with C. rosea IK726 has an enhanced chitinolytic and glucanolytic activity compared to the activity in non-treated barley in pot experiments with field soil. Identification of chitinases from IK726 and studies of their role in interactions with pathogens have therefore been addressed in a recently initiated project. Preliminary results indicate that IK726 produces three types of chitinases, which seem to be regulated by glucose. Development of degenerated primers for cloning of an endochitinase is in progress. | Mette Lübeck Inge M B Knudsen Birgit Jensen Mojtaba Mamarabadi Dan Funck Jensen | 2004 | 浙江大学学报(农业与生命科学版)2004，30，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员